RegCell lands $44M Series A to take Nobel-winning Tregs into clinic

For nearly 50 years, Shimon Sakaguchi has been studying and working on regulatory T cells, figuring out how the immune system "governs itself." Now, the Nobel laureate's decade-old biotech RegCell is gearing up for clinical ...